Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 882 results for "for merck"

Merck Millipore launches Steritest Symbio Pumps for improved s...

Merck Millipore, the Life Science division of Merck, has launched Steritest Symbio Pumps for easier, safer and more reliable sterility testing of pharmaceutical products in laminar flow hoods, isolators and clean rooms. The Steritest Symbio Pumps ... PharmaBiz, 20 hours ago

221 images for for merck

American Banking News, 3 days ago
Jutia Group, 3 days ago
Pharma Letter, 2 days ago
Pharma Letter, 2 days ago
Orlando Sentinel, 5 days ago
Pharmafocus, 4 days ago
Pharma Letter, 3 days ago, 3 days ago
Lawyer Herald, 5 days ago
Yahoo! News, 5 days ago
Bio Spectrum Asia

Merck & Co inks pact with Advaxis

Singapore : Merck has collaborated with Advaxis to study the combination of Advaxis's Lm-LLO cancer immunotherapy, and pembrolizumab Merck's investigational anti PD-1 antibody, for the treatment of prostate cancer. The collaboration will evaluate ...
 Bio Spectrum Asia1 day ago Merck Collaboration Could Add $150M To Advaxis' Present Value  Seeking Alpha4 days ago Advaxis, Merck to Evaluate Immunotherapy Combo Drug  Contract Pharma5 days ago

US company introduces medicine to manage asthma

Accra, Aug. 29, GNA - Merck Sharp & Dohme (MSD) a US pharmaceutical company and one of the largest pharmaceutical companies in the world, has introduced Singulair®, a drug that treats asthma and allergic rhinitis in children and adults. In a bid ...
 Ghana News Agency1 day ago

Why J&J Wants to Divest Medical Devices Business

Big old-school conglomerates are selling. First it was Dow Chemical, Merck and General Electric putting up units for sale. Now its Johnson & Johnson, the world's biggest maker of health-care products, that is seeking a buyer for its medical devices ...
 Yahoo! Finance1 day ago

Mylan A Tough Contender In The Biosimilar Anti-Diabetes Race

Mylan is going head-to-head with other pharmaceutical giants like Eli Lilly and Merck in competing to launch a biosimilar of Sanofi\\'s drug Lantus, which is expected to go off-patent by early 2015 Page 1 of 2 Published: August 29, 2014 at ...
 Bidness Etc1 day ago

Pfizer and Merck hook-up for cancer treatment trial

Pfizer and Merck are to collaborate in a trial of a combination therapy to target lung cancer. A new partnership between Pfizer and Merck Sharp and Dohme will see the pair combining their own drugs to create a combination therapy to be tested on ...
 Pharma Field2 days ago Pfizer, Merck ink pact to explore potential of combo of Xalkori and pembrolizumab in phase 1b clinical study  PharmaBiz2 days ago Merck & Pfizer team up  NBR.com3 days ago ADXS: Advaxis Enters Into Collaboration with Merck Using its Immunotherapy for the Treatment of Prostate …  Yahoo! Finance3 days ago
Pharma Letter

Merck Spent CNY650mn Building China Factory

Merck KGaA's global second largest pharmaceutical factory with an investment of CNY 650 million started construction in Nantong, is expected to come into official production in 2017 and specializes in diabetes drug Glucophage, thyroid drug Thyrozol ...
 Individual.com2 days ago Merck KGaA starts work on what will be its second-largest plant  FiercePharmaManufacturing2 days ago Merck Serono starts building $105 million plant in Nantong, China27-08-2014  Pharma Letter2 days ago Merck Serono Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China, its Second Largest Worldwide  Individual.com3 days ago
Reuters India

Merck Collaborates With Pfizer Again For Its PD-1 Immunotherapy

Merck has joined hands with Pfizer to test the efficacy of the combination of its Pembrolizumab and Pfizer\\'s Xalkori. Both drugs have been developed to treat lung cancer Page 1 of 2 Click Ticker to See live coverage Pfizer Inc. ( PFE ...
 Bidness Etc3 days ago Pfizer to test Xalkori lung cancer drug with Merck immunotherapy  Yahoo! Finance4 days ago Pfizer looks to Merck's experimental immunotherapy to boost outcomes for lung cancer drug  MedCity News4 days ago RPT-UPDATE 2-Pfizer to test Xalkori lung cancer drug with Merck immunotherapy  CNBC4 days ago

Merck receives FDA approval for insomnia drug

(MarketLine via COMTEX News Network) -- Merck & Co., Inc. has received approval from the FDA for BELSOMRA for adults with insomnia who have difficulty falling asleep and/or staying asleep. BELSOMRA is a highly selective antagonist for orexin ...
 PredictWallStreet1 day ago Merck's Melanoma Drug To Get FDA Approval Earlier Than Expected  Bidness Etc4 days ago Merck Wins Approval for First-of-Kind Insomnia Drug  FDA News1 week ago U.S. FDA approves Merck insomnia drug  Reuters2 weeks ago

Advaxis teams up with Merck in prostate cancer

10:46 ET | About: Advaxis Inc. (ADXS) Shares of nan cap Advaxis (ADXS +12.9%) jump on a 6x surge in volume in response to its announcement of a clinical trial collaboration with Merck (MRK +1%) that will evaluate the combination of Advaxis' Lm-LLO ...
 Seeking Alpha5 days ago Merck and Advaxis team up on immuno-oncology  Pharmafocus4 days ago Advaxis, Merck to test immune therapies against prostate cancer  Reuters5 days ago Advaxis, Merck to Investigate Prostate Cancer Combo Therapy  Genetic Engineering News5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less